Interviews with participating patients from the VenoValve® U.S. Pivotal Trial ...

Consultant vascular surgeon Ian Nichol, who works at The James Cook University Hospital, saved the leg of Chris Dolan, 50 ...

MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced ...

The FDA's approval of VenoValve's PMA has the potential to significantly expand NVNO's portfolio of bioprosthetic solutions.

A new federal payment policy will sharply reduce the number of specialty wound care products available to certain Medicare patients.

Cardinal Health CAH recently launched the Kendall SCD SmartFlow Compression System in the United States. The system is the ...

Clinical Meaningful Benefit Responder Rate7.91 Point Average rVCSS Improvement for the Clinically Meaningful Benefit Responder Cohort75% ...

November 20, 2024—enVVeno Medical Corporation announced 1-year data on all patients from SAVVE, the United States pivotal trial of the company&r ...

Definitive One Year Data from PMA Application to be Presented Wednesday at 51st Annual VEITH SymposiumCompany to Host a Conference Call with the PIs Presenting the Pivotal Trial Data on Wednesday, Nov ...

Medical products group Convatec has expressed disappointment with a ruling which excludes its InnovaMatrix product from ...

ConvaTec maintained InnovaMatrix is an excellent product delivering strong results for patients and is trusted by clinicians. The firm remains confident of securing DFU/VLU coverage and as such, ...

Report with market evolution powered by AI - The global wound care market size is estimated to grow by USD 6.95 billion from ...